Skip to content

Clinical trials

Phase 2 Osteosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteosarcoma Phase: Phase 2 Country / region: United States Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20022
20032
20043
20063
20075
20082
20095
20112
20122
20135
20143
20154
20164
20178
20184
20192
20205
20215
20224
20231
20242
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Active, not recruiting16
Recruiting10
Terminated9
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)29
Memorial Sloan Kettering Cancer Center14
M.D. Anderson Cancer Center6
St. Jude Children's Research Hospital5
Children's Oncology Group4
Sarcoma Alliance for Research through Collaboration3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Dana-Farber Cancer Institute2
Emerald Clinical Inc.2
Northwestern University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteosarcoma97
Sarcoma54
Rhabdomyosarcoma32
Neuroectodermal Tumors, Primitive, Peripheral31
Neuroblastoma30
Sarcoma, Ewing22
Wilms Tumor22
Hepatoblastoma19
Medulloblastoma19
Ependymoma16

Trials

Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.